Nonmedical Prescription Drug Sales: A Focus on Stigma and (Perceived) Safety

The prevalence of nonmedical use of prescription drugs appears to be growing steadily. The number of individuals reporting abuse of controlled prescription drugs increased from 7.8 million in 1992 to 15.1 million in 2003 (CASA, 2005). While there are a few studies of large-scale pharmaceutical diversion to nonmedical markets, a large gap in the research exists regarding the chain of distribution of prescription medications. Little is known about the settings for diversion and motives for selling prescription drugs in illicit markets. According to Fountain and colleagues (2000), “market-places” for illicit prescription drug sales often arise in the vicinity of drug treatment agencies, pharmacies and needle exchanges. This qualitative research project will provide much needed information about the nature of nonmedical prescription drug sales in the San Francisco Bay Area. Specifically, this project will provide information regarding the impact of nonmedical prescription drug sales on relationships, lifestyles, as well as health and social consequences of use. This specific presentation will focus on the issues of stigma surrounding nonmedical prescription drug sales such as attitudes about the safety/risk of selling pharmaceutical drugs compared to other street/illicit drugs (i.e. cocaine, heroin).